Cognitive-behavioral therapy for depression in Parkinson's disease: A randomized, controlled trial

American Journal of Psychiatry

Volumn 168, Issue 10, 2011, Pages 1066-1074

  Dobkin, Roseanne D ^a,b   Menza, Matthew ^a,b   Allen, Lesley A ^a,b   Gara, Michael A ^a,b   Mark, Margery H ^a,b   Tiu, Jade ^a,b   Bienfait, Karina L ^a,b   Friedman, Jill ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CAREGIVER BURDEN; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEASIBILITY STUDY; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT MONITORING; PHYSICAL DISABILITY; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SOCIAL INTERACTION; SOCIAL SUPPORT; SYMPTOMATOLOGY; THINKING IMPAIRMENT; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 80053243226     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10111669     Document Type: Article

References (45)

1. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Garcia-Sanchez C, Gironell A: Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 2008; 23:1889-1896
2. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G: Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008; 23:1420-1427
3. Cummings JL: Depression and Parkinson's disease. Am J Psychiatry 1992; 149:443-454
4. Reijnders MA, Ehrt U, Weber WEJ, Aarsland D, Leentjens AF: A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23:183-189 (Pubitemid 351311545)
5. Menza MA, Robertson-Hoffmann DE, Bonapace AS: Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993; 34:465-470 (Pubitemid 23337729)
6. Santangelo G, Vitale C, Trojano L, Longo K, Cozzolino A, Grossi D, Barone P: Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. J Neurol 2009; 256:632-638
7. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG: A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55:377-382
8. Global Parkinson's Disease Survey Steering Committee: Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002; 17:60-67
9. Martinez-Martin P, Forjaz MJ, Frades-Payo B, Rusiñol AB, Fernández-García JM, Benito-León J, Arillo VC, Barberá MA, Sordo MP, Catalán MJ: Caregiver burden in Parkinson's disease. Mov Disord 2007; 22:924-931 (Pubitemid 46999286)
10. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A: A controlled trial of antidepressants in patients with Parkinson's disease and depression. Neurology 2009; 72:886-892
11. Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P, Destee A, Bordet R, Defebvre L: Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized placebo controlled study. Mov Disord 2008; 23:850-857
12. Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D: Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9:573-580
13. da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC: Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study of omega 3 fatty acid supplementation. J Affect Disord 2008; 111:351-359
14. Serfaty MA, Haworth D, Blanchard M, Buszewicz M, Murad S, King M: Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care. Arch Gen Psychiatry 2009; 66:1332-1340
15. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, van der Wende J, Dwyer P, Dick LP: Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000; 68:356-361
16. Veazey C, Cook KF, Stanley M, Lai EC, Kunik ME: Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings 2009; 16:243-253
17. Feeney F, Egan S, Gasson N: Treatment of depression and anxiety in Parkinson's disease: a pilot study using group cognitive behavioural therapy. Clin Psychol 2005; 9:31-38
18. Cole K, Vaughan FL: Brief cognitive-behavioral therapy for depression associated with Parkinson's disease: a single case series. Behav Cogn Psychother 2005; 33:89-102 (Pubitemid 40175544)
19. Dobkin RD, Allen LA, Menza M: Cognitive behavior therapy for depression in Parkinson's disease: a pilot study. Mov Disord 2007; 22:946-952 (Pubitemid 46999289)
20. Dreising H, Beckmann J, Wermuth L, Skovlund S, Bech P: Psychologic effects of structured cognitive psychotherapy in young patients with Parkinson's disease: a pilot study. Nordic J Psychiatry 1999; 53:217-221 (Pubitemid 29505032)
21. Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Bunchin J, Pava J, Alpert JE: Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics 2010; 51:124-129
22. Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AH: Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 2005; 66:455-468 (Pubitemid 40593574)
23. Borkovec T, Sibrava NJ: Psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. J Clin Psychol 2005; 61:805-818 (Pubitemid 41153532)
24. Gelb DJ, Oliver E, Gilman S: Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56:33-39 (Pubitemid 29046907)
25. Guy W: ECDEU Assessment Manual for Psychopharmacology. Washington, DC, US Department of Health, Education, and Welfare, 1976
26. Marsh L, McDonald WM, Cummings J, Ravina B, NINDS/NIMH Work Group on Depression and Parkinson's Disease: Provisional Diagnostic Criteria for Depression in Parkinson's Disease: report of an NINDS/NIMH Work Group. Mov Disord 2006; 21:148-158
27. Mattis S: Dementia Rating Scale. Odessa, Fla, Psychological Assessment Resources, 1988
28. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
29. Hamilton M: The assessment of anxiety status by rating. Br J Med Psychol 1959; 32:50-55
30. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weisman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991; 48:851-855
31. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979
32. Alloy LB, Abramson LY: The Temple-Wisconsin Cognitive Vulnerability to Depression (CVD) project: conceptual background, design, and methods. J Cogn Psychother 1999; 13:227-262 (Pubitemid 30010795)
33. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric research and practice. J Psychiatr Res 1989; 28:193-213 (Pubitemid 19144991)
34. Ware JE, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 1992; 30:473-483
35. Carver CS: You want to measure coping but your protocol is too long: consider the brief COPE. Int J Behav Med 1997; 4:92-100
36. Dobkin RD, Panzarella C, Alloy LB, Cascardi M, Truesdell K, Gara M: Assessing an interpersonal- cognitive risk factor for depression: preliminary validation of the Social Feedback Questionnaire. J Soc Pers Relat 2007; 24:765-780
37. Cousins R, Davies ADM, Turnball CJ, Playfer JR: Assessing caregiver distress: a conceptual analysis and brief scale. Br J Clin Psychol 2002; 41:387-403 (Pubitemid 35439330)
38. Fahn S, Elton RL, UPDRS Development Committee: Unified Parkinson's Disease Rating Scale, in Recent Developments in Parkinson's Disease. Edited by Fahn S, Marsden CD, Calne DB, Goldstein M. Florham Park, NJ, Macmillan Health Care Information, 1987, pp 153-163
39. Dobkin RD, Menza M, Bienfait KL: CBT for the treatment of depression in Parkinson's disease: a promising non-pharmacological approach. Expert Rev Neurother 2008; 8:27-35
40. Young J, Beck AT: Cognitive Therapy Scale Rating Manual. Philadelphia, University of Pennsylvania Psychotherapy Research Unit, 1980
41. Driessen E, Hollon SD: Cognitive behavioral therapy for mood disorders: efficacy, moderators, and mediators. Psychiatr Clin N Am 2010; 33:537-555
42. Marsh L, Williams JR: Effect of depression remission status on physical disability in Parkinson's disease: longitudinal cohort study (abstract). Mov Disord 2007; 22:XIV-XV
43. Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R: The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom 2009; 78:275-284
44. Schrag A, Barone P, Brown RG, Leentjens AFG, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG: Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22:1077-1092 (Pubitemid 47067217)
45. Weintraub D, Stern MB: Psychiatric complications in Parkinson's disease. Am J Geriatr Psychiatry 2005; 13:844-851